Hospital
Kaiser Foundation Hospitals
Kaiser Foundation Hospitals was paid $5.33M by Medicaid between Aug 2023 and Dec 2024, across 157 billing codes. Its largest line is 99283, emergency room visit (moderate) — 63% of everything it billed.
33Billing provider infoKAISER FOUNDATION HOSPITALS
SAN MARCOS, CA 92078
SAN MARCOS, CA 92078
33aNPI1558080861assigned 08/22/2022
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.33M
24GClaims157,071
24DCodes billed157
24AFirst – last monthAug 2023 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#220 of 410
Median peer was paid$6.90M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 37,553 | $1.13M | |
| 2024incomplete | 119,518 | $4.20M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 63% | 6,343 | 5,798 | $3.36M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 913 | 887 | $583K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 6.0% | 249 | 247 | $321K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.1% | 649 | 635 | $217K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.6% | 459 | 452 | $137K |
| G0378 | Hospital observation service, per hour | 1.0% | 791 | 519 | $54K |
| 86900 | <1% | 570 | 525 | $33K | |
| 71045 | Radiologic examination, chest; single view | <1% | 687 | 650 | $32K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 423 | 408 | $27K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 393 | 379 | $25K |
| 86885 | <1% | 351 | 344 | $25K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 80 | 80 | $22K |
145 more codes
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,900 | $21K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,690 | $19K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 226 | $19K |
| 82565 | <1% | 10,427 | $18K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 31 | $18K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,549 | $17K |
| 84702 | <1% | 2,601 | $16K | |
| 80051 | <1% | 8,473 | $14K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,996 | $13K |
| 80061 | Lipid panel | <1% | 1,243 | $13K |
| 84460 | <1% | 5,476 | $13K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 66 | $12K |
| 83880 | <1% | 1,268 | $11K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 503 | $11K |
| 86901 | <1% | 570 | $10K | |
| 86480 | <1% | 157 | $9K | |
| 83970 | <1% | 493 | $9K | |
| 86141 | <1% | 1,156 | $9K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 380 | $9K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 380 | $9K |
| 85027 | <1% | 2,020 | $8K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 55 | $8K |
| 93017 | <1% | 48 | $8K | |
| 82247 | <1% | 4,361 | $7K | |
| 84075 | <1% | 4,254 | $7K | |
| 93971 | <1% | 81 | $7K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 314 | $7K |
| 82728 | <1% | 699 | $7K | |
| 81003 | <1% | 6,081 | $7K | |
| 82607 | <1% | 538 | $6K | |
| 86780 | <1% | 434 | $6K | |
| 86803 | <1% | 480 | $6K | |
| 87505 | <1% | 80 | $6K | |
| 80076 | <1% | 986 | $6K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 316 | $5K |
| 83735 | <1% | 2,248 | $5K | |
| 82310 | <1% | 2,025 | $5K | |
| 82947 | <1% | 6,562 | $5K | |
| 84450 | <1% | 3,441 | $5K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,323 | $4K |
| 84520 | <1% | 7,357 | $4K | |
| 81513 | <1% | 56 | $4K | |
| 83550 | <1% | 735 | $4K | |
| 83690 | <1% | 2,846 | $4K | |
| 0450 | Emergency room services | <1% | 78 | $4K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 60 | $3K |
| 83520 | <1% | 338 | $3K | |
| 87340 | <1% | 356 | $3K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 44 | $3K |
| 83540 | <1% | 743 | $3K | |
| 85610 | <1% | 2,224 | $3K | |
| 0637 | <1% | 11,765 | $2K | |
| 82570 | <1% | 624 | $2K | |
| 82746 | <1% | 266 | $2K | |
| 87481 | <1% | 75 | $2K | |
| 84439 | <1% | 415 | $2K | |
| 82040 | <1% | 1,282 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 56 | $2K |
| 84132 | <1% | 891 | $2K | |
| 73562 | <1% | 32 | $2K | |
| 73630 | <1% | 29 | $2K | |
| 85730 | <1% | 588 | $2K | |
| 87088 | <1% | 844 | $2K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 42 | $2K |
| 84295 | <1% | 677 | $2K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 126 | $2K |
| 84156 | <1% | 634 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,446 | $2K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 12 | $1K |
| 84100 | <1% | 978 | $1K | |
| 82043 | <1% | 531 | $1K | |
| 85652 | <1% | 874 | $1K | |
| 84550 | <1% | 552 | $1K | |
| 84484 | <1% | 2,048 | $1K | |
| 82950 | <1% | 295 | $1K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 158 | $1K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 27 | $1K |
| 82248 | <1% | 600 | $1K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 456 | $1K |
| 73610 | <1% | 12 | $1K | |
| 85379 | <1% | 481 | $1K | |
| 87449 | <1% | 116 | $996.00 | |
| 82105 | <1% | 110 | $987.00 | |
| 86038 | <1% | 97 | $980.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 368 | $975.04 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,327 | $954.22 |
| 84134 | <1% | 82 | $756.00 | |
| 86364 | <1% | 60 | $650.00 | |
| 73030 | <1% | 14 | $642.84 | |
| 82550 | <1% | 256 | $634.60 | |
| 80197 | <1% | 90 | $606.00 | |
| 84165 | <1% | 125 | $598.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 333 | $570.39 |
| 82977 | <1% | 77 | $531.00 | |
| 87040 | <1% | 1,169 | $454.22 | |
| 85014 | <1% | 325 | $380.00 | |
| 84153 | <1% | 41 | $375.00 | |
| 85018 | <1% | 301 | $368.00 | |
| 82962 | <1% | 906 | $352.82 | |
| 83721 | <1% | 40 | $300.00 | |
| 86308 | <1% | 69 | $275.00 | |
| 87324 | <1% | 54 | $270.00 | |
| 87497 | <1% | 14 | $258.00 | |
| 86704 | <1% | 28 | $244.00 | |
| 87210 | <1% | 104 | $242.56 | |
| 83605 | <1% | 744 | $238.62 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,237 | $194.26 |
| 0250 | <1% | 938 | $161.33 | |
| 82077 | <1% | 99 | $147.64 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 653 | $145.20 |
| 97161 | <1% | 56 | $133.13 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 68 | $132.26 |
| 83615 | <1% | 32 | $122.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 420 | $104.43 |
| 87081 | <1% | 135 | $99.68 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 783 | $93.64 |
| 90656 | <1% | 203 | $90.91 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,450 | $90.77 |
| 82150 | <1% | 14 | $87.00 | |
| 90686 | <1% | 124 | $76.08 | |
| J1815 | Injection, insulin, per 5 units | <1% | 140 | $73.86 |
| G0008 | Administration of influenza virus vaccine | <1% | 108 | $73.85 |
| 84145 | <1% | 19 | $70.00 | |
| 87205 | <1% | 48 | $70.00 | |
| 83718 | <1% | 13 | $69.95 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 340 | $55.70 |
| J3490 | Unclassified drugs | <1% | 319 | $55.23 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,165 | $54.00 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 295 | $50.86 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 582 | $46.85 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 286 | $45.31 |
| 82465 | <1% | 14 | $34.41 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 174 | $26.72 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 204 | $24.02 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 21 | $20.67 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 250 | $15.68 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 88 | $13.52 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 70 | $13.22 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 170 | $10.30 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 37 | $0.00 |
| 90662 | 0% | 89 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 44 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 13 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 16 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFINLEY, ELIZABETH (SENIOR VICE PRESIDENT/AREA MANAGER)
| Provider | Location | Paid |
|---|---|---|
| Kaiser Foundation Hospitals | San Diego, CA | $93.22M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.